Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
Crossref DOI link: https://doi.org/10.1007/s13300-020-00942-7
Published Online: 2020-10-14
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Patoulias, Dimitrios
Papadopoulos, Christodoulos
Katsimardou, Alexandra
Toumpourleka, Maria
Doumas, Michael
Text and Data Mining valid from 2020-10-14
Version of Record valid from 2020-10-14
Article History
Received: 10 September 2020
Accepted: 3 October 2020
First Online: 14 October 2020